Nanobiotix wins people’s choice award

Oct 05, 2017
Award winner noted for innovative targeting

Nanobiotix, the Paris-based nano-medicine company that aims to revolutionize radiotherapy, has been named the people’s choice award winner at the IR Magazine Global Forum Conference & Awards in Paris.

Nanobiotix won the award for its innovative targeting initiative focusing on large biotech funds.

For the 2017 awards, IR Magazine gave companies the opportunity to nominate themselves, free of charge, for the people’s choice award. This award encouraged entries from publicly listed companies that have made an outstanding contribution to the practice of IR and the community of IR professionals.

The other companies short-listed in this category were:

  • General Motors – for its CFO Office Hours calls for investors and analysts and its GMC Acadia Ride and Drive event in New York
  • Recruit Holdings – for getting management from a private and complex business on board for IR activities
  • Scotiabank – for an investor event held in the firm’s digital factory in Toronto showcasing its digital transformation strategy.
Sign up to get stories direct to your inbox
logo-black logo-black
Loading